These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1911078

  • 1. [Cancer of the breast and the receptor status].
    Buonomo O, Serao A, Muggianu A, Guglielmelli E, Davoli E, Amori A.
    G Chir; 1991 Apr; 12(4):274-7. PubMed ID: 1911078
    [Abstract] [Full Text] [Related]

  • 2. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S, Schröder W, Steinhagen G, Koch R, Veuskens U, Schmitz FJ, Handt S, Böcking A.
    Anticancer Res; 1997 Apr; 17(6D):4723-9. PubMed ID: 9494596
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.
    Kurebayashi J, Ishida T, Higashi Y, Suemasu K, Nomoto C, Yoshida K.
    Jpn J Clin Oncol; 1990 Sep; 20(3):271-80. PubMed ID: 2255103
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
    Kyndi M, Sørensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J, Danish Breast Cancer Cooperative Group.
    J Clin Oncol; 2008 Mar 20; 26(9):1419-26. PubMed ID: 18285604
    [Abstract] [Full Text] [Related]

  • 8. Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels.
    Di Fronzo G, Coradini D, Cappelletti V, Miodini P, Granata G, Schwartz M, Panko WB.
    Anticancer Res; 1990 Mar 20; 10(6):1699-705. PubMed ID: 2285244
    [Abstract] [Full Text] [Related]

  • 9. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
    Honma N, Horii R, Iwase T, Saji S, Younes M, Takubo K, Matsuura M, Ito Y, Akiyama F, Sakamoto G.
    J Clin Oncol; 2008 Aug 01; 26(22):3727-34. PubMed ID: 18669459
    [Abstract] [Full Text] [Related]

  • 10. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
    Skasko E, Paszko Z, Mazur S.
    Neoplasma; 2005 Aug 01; 52(1):10-7. PubMed ID: 15739020
    [Abstract] [Full Text] [Related]

  • 11. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
    Voogd AC, Crommelin MA, Repelaer van Driel OJ, Tutein Nolthenius-Puylaert MC, Vreugdenhil G, Coebergh JW.
    Ned Tijdschr Geneeskd; 1998 Aug 01; 142(31):1772-8. PubMed ID: 9856143
    [Abstract] [Full Text] [Related]

  • 12. Prognostic implications of HER-2 status in steroid receptor-positive, lymph node-negative breast carcinoma.
    Peiró G, Adrover E, Aranda FI, Peiró FM, Niveiro M, Sánchez-Payá J.
    Am J Clin Pathol; 2007 May 01; 127(5):780-6. PubMed ID: 17439837
    [Abstract] [Full Text] [Related]

  • 13. [Long-term prognostic role of steroid receptors in cancer of the breast].
    Broët P, Pichon MF, Magdelenat H, Delarue JC, Spyratos F, Basuyau JP, Saez S, Rallet A, Courrière P, Millon R, Asselain B.
    Bull Cancer; 1998 Apr 01; 85(4):347-52. PubMed ID: 9752299
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP, Hoop JG, van Beers M, van Rodijnen N, Pannebakker M, Nap M.
    Cytometry B Clin Cytom; 2005 Mar 01; 64(1):43-52. PubMed ID: 15668953
    [Abstract] [Full Text] [Related]

  • 16. Assessment of results of estrogen and progesterone receptor assays performed in a community hospital.
    Szakacs JG, Arroyo JG, Girgenti AJ.
    Ann Clin Lab Sci; 1986 Mar 01; 16(4):266-73. PubMed ID: 3740795
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
    Foekens JA, Portengen H, van Putten WL, Peters HA, Krijnen HL, Alexieva-Figusch J, Klijn JG.
    Cancer Res; 1989 Nov 01; 49(21):5823-8. PubMed ID: 2676151
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.
    Paradiso A, Tommasi S, Mangia A, Lorusso V, Simone G, De Lena M.
    Cancer Res; 1990 May 15; 50(10):2958-62. PubMed ID: 2334898
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.